Lund center for Stem Cell Biology and Cell Therapy is one of six Swedish strategic centers of excellence in life sciences, supported by the Swedish Foundation for Strategic Research. Established in January 2003, the center focuses on stem cell and developmental biology of the central nervous and blood systems, and development of stem cell and cell replacement therapies in these organ systems as well as research in non-mammalian model systems.
Tamar Memanishvili from the Kokaia lab, recieved first prize for the best poster at the Drug Discovery & Therapy World Congress 2014, June 16-19 Boston, MA, USA. Name of the poster: Biodegradable Amino Acid-Based Polymeric Microparticles for Improved Functional Recovery in Stem Cell Therapy After Stroke.
Wednesday June 18, 2014, Time: 14-16. Segerfalksalen, BMC, Visiting address: Sölvegatan 17, Lund. With Chrysi Kannellopoulou, Ph.D., Senior Scientist, Laboratory of Immunology, NIH/NIAID, Bethesda and Stefan Muljo, Ph.D., Chief, Integrative Immunobiology Unit, Laboratory of Immunology, NIH/NIAID, Bethesda
New paper in Cell Reports. The Miharada group and the Karlsson group report that an RNA binding protein Dppa5 is a novel regulator of hematopoietic stem cells (HSCs) that reduces endoplasmic reticulum (ER) stress. The findings suggest that better protein quality control through a reduction in ER stress improves HSC function.